Fig. 2From: The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphomaProgression-free survival (PFS) in the cohort of 102 patients with negative interim PET, stratified in two groups according to KIR haplotype (p = NS). CI confidence intervalBack to article page